Targeted radionuclide treatment for neuroendocrine tumors improves quality of life
Malignant neuroendocrine tumors, commonly called NETs, are easy to miss and associated with discouraging survival rates and poor quality of life. A study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine ...
Jun 12, 2017
0
0